Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-05-02
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Change of Lifestyle by Persons in Risk of Type 2 Diabetes
NCT00202748
Lifestyle Intervention in Individuals With Low or High Genetic Risk for Type 2 Diabetes
NCT02709057
A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes
NCT07262788
A Diabetes Prevention Study Targeting High Risk Individuals With Education and Ongoing Support
NCT00677937
Diabetes Prevention Translation: the Healthy Lifestyle Project
NCT01050205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participants will be randomized into three study arms, 20 participants in each. One group, the intervention group, will receive the mobile app, the second group will receive group-based lifestyle intervention at the HLCs and the third group will receive group based lifestyle intervention at the HLCs and a mobile application. The middle arm will serve as the control arm for both the non-inferiority trial ( mobile application group and HLC lifestyle intervention only) and for the superiority trial (HLC lifestyle intervention plus mobile app and HLC intervention only).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mobile application
This group will receive individual guidance via the mobile application (12 weeks)
Mobile application
Individual lifestyle intervention via an mobile application
Group-based lifestyle intervention at the Healthy Lifestyle Centres
This group will receive a group-based lifestyle intervention program at a Healthy Lifestyle Centre (12 weeks)
Group-based lifestyle intervention
Group-based life style intervention at a Healthy Lifestyle Centre (ususal care)
Group-based lifestyle intervention at a Healthy Lifestyle Centre and recieving a mobile application
This group will receive a group-based lifestyle intervention program at a Healthy Lifestyle Centre plus the mobile application (12 weeks)
Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"
Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile application
Individual lifestyle intervention via an mobile application
Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"
Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"
Group-based lifestyle intervention
Group-based life style intervention at a Healthy Lifestyle Centre (ususal care)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* prediabetes
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo Metropolitan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birgitta Blakstad Nilsson, Phd
Role: PRINCIPAL_INVESTIGATOR
OsloMet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OsloMet
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
887029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.